English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/208654
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

The fate of magnetic nanoparticles after intratumoral injection

AuthorsBeola, Lilianne; Fernández, Y.; Fratila, Raluca M.; Fuente, Jesús M. de la; Grazú, Valeria; Asín, Laura; Gutiérrez, Lucía
Issue Date2019
Citation2nd Spanish Conference on Biomedical Applications of Nanomaterials (2019)
AbstractIn recent years, there has been significant research focusing on the use of magnetic nanoparticles for biomedical applications. To date, most of this research has focused on the development of the particles, their surface functionalization and the experiments leading to the proof of concept of the different biomedical applications. However, before these particles reach the clinical practice, several aspects regarding their biological fate, biodistribution, and toxicity, must be assessed. Previous research on the biodistribution and degradation of magnetic nanoparticles after systemic administration has shown that nanoparticles accumulate mainly in the spleen and liver of animals and that the degradation kinetics of magnetic nanoparticles may be very slow. However, there is little information regarding the biodistribution of magnetic nanoparticles when different administration routes are used. In this study, we have evaluated the degradation and biodistribution of magnetic nanoparticles after intratumoral injection. We have used a human pancreatic heterotopic-xenograft tumour model in Balb/c nude mice. Animals received a single intratumoral administration of magnetic nanoparticles. The migration of the particles to other organs was evaluated in two different scenarios: one in which no further treatment was applied to the animals and other in with an alternating magnetic field for hyperthermia treatment was applied three times along a week. The biodistribution and degradation over time of the particles has been followed by AC magnetic susceptibility. These experiments have allowed us to evaluate the effect of the magnetic hyperthermia treatment on the nanoparticles biodistribution.
DescriptionResumen del trabajo presentado a la 2nd Spanish Conference on Biomedical Applications of Nanomaterials (SBAN), celebrada en Madrid del 6 al 7 de junio de 2019.
URIhttp://hdl.handle.net/10261/208654
Appears in Collections:(ICMA) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
fateinjec.pdf169,95 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.